Skip to content
MARKETS / NYSE / APT
NYSE · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · SMALL CAP

Alpha PRO Tech Ltd. APT

16 fiscal years on record · USD · FY2025 reported · SEC filings only
$59.1M
▲ 2.3% YoY
$3.5M
▼ 10.1% YoY
$1.7M
▼ 8.5% YoY
In brief

What this company does

ALPHA PRO TECH, LTD. ("Alpha Pro Tech," the "Company," "we," "our" or "us") is the parent company of Alpha Pro Tech, Inc. and Alpha ProTech Engineered Products, Inc. The Company was incorporated in the State of Delaware on July 1, 1994, as a successor to a business that was organized in 1983. Alpha Pro Tech is in the business of protecting people, products and environments. We accomplish this by developing, manufacturing and marketing a line of high-value, disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets through our wholly-owned subsidiary, Alpha Pro Tech, Inc. Our products are grouped into two business segments: (1) the Building Supply segment, consisting of construction weatherization products, such as housewrap, housewrap accessories including window and door flashing and seam tape, synthetic roof underlayment and synthetic roof underlayment accessories, as well as other woven materials; and (2) the Disposable Protective Apparel segment, consisting of disposable protective garments (including shoecovers, bouffant caps, coveralls, gowns, frocks and lab coats), face masks and face shields. As of March 2, 2026, we had 122 full-time employees and one part-time employee, including 19 employees at our principal executive office in Aurora, Ontario, Canada; 39 employees at our Disposable Protective Apparel segment facility in Nogales, Arizona; 46 employees at our Building Supply segment facility in Valdosta, Georgia; 17 employees on our sales and marketing team, located in various areas throughout the United States; and 1 employee in China.

Written from the business description in Alpha Pro Tech, Ltd.'s annual report to the U.S. Securities and Exchange Commission, filed 11 March 2026. Every sentence was checked against that document before publication.

Growth
USD 59.1M
Revenue, FY2025 · full 16-year series below
Revenue $M Net income $M
FY2025 · Revenue 59.1 · Net income 3.5
40M80M201020122014201620182020202220242025
Compound annual growth
−1.6%
−10.5%
+2.8%
+2.3%
+2.5%
−33.4%
+13.0%
+6.9%
+8.3%
−29.7%
+18.6%
+12.0%
−4.2%
+38.0%
+9.5%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −10.5% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
6 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 6.5% · Net 6.0%
10%20%30%201020122014201620182020202220242025
ROE
FY2025 · ROE 5.7%
20%40%201020122014201620182020202220242025

Each USD of equity produced 6 cents of profit this year.

Cash & shareholders
USD 3.3M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 1.7
8M16M-2M-4M201020122014201620182020202220242025
Net buybacks $M Dividends $M
FY2025 · Dividends — · Net buybacks 3.3
2.5M5.0M20112013201520172019202120232025

USD 3.3M in buybacks — 95% of the year's profit went back to shareholders.

Total assetsUSD 74.1M
EquityUSD 62.5M
CashUSD 17.0M
Current ratio12.94×

Equity funds 84% of total assets.

The 16-year record
16 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 2025202420232022202120202019201820172016201520142013201220112010
Revenue $B0.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.0
Operating income $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
EBITDA $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Income tax $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Net income $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Free cash flow $B0.00.00.00.0−0.00.00.00.00.00.00.0−0.00.0−0.00.0−0.0
EPS, diluted $0.330.350.350.260.501.920.230.260.180.190.060.150.110.050.040.06
Dividend / sh $················
Payout %················
ROE %5.76.36.85.411.258.69.211.48.29.22.87.55.92.82.63.7
Shares out B0.010.010.010.010.010.010.010.010.010.020.020.020.020.020.020.02

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 80 reconciliationsAUDITED

Reconciled in 16 of 19 fiscal years. 15 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityOrthopedic, Prosthetic & Surgical Appliances & Supplies
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2010

Share this section

Download image